Literature DB >> 14688397

Chemokines promote quiescence and survival of human neural progenitor cells.

Mitchell D Krathwohl1, Jodi L Kaiser.   

Abstract

Many cell types in the brain express chemokines and chemokine receptors under homeostatic conditions, arguing for a role of these proteins in normal brain processes. Because chemokines have been shown to regulate hematopoietic progenitor cell proliferation, we hypothesized that chemokines would regulate neural progenitor cell (NPC) proliferation as well. Here we show that chemokines activating CXCR4 or CCR3 reversibly inhibit NPC proliferation in isolated cells, neurospheres, and in hippocampal slice cultures. Cells induced into quiescence by chemokines maintain their multipotential ability to form both neurons and astrocytes. The mechanism of chemokine action appears to be a reduction of extracellular signal-related kinase phosphorylation as well as an increase in Reelin expression. The inhibitory effects of chemokines are blocked by heparan sulfate and apolipoprotein E3 but not apolipoprotein E4, suggesting a regulatory role of these molecules on the effects of chemokines. Additionally, we found that the chemokine fractalkine promotes survival of NPCs. In addition to their role in chemotaxis, chemokines affect both the survival and proliferation of human NPCs in vitro. The presence of constitutively expressed chemokines in the brain argues that under homeostatic conditions, chemokines promote survival but maintain NPCs in a quiescent state. Our studies also suggest a link between inflammatory chemokine production and the inhibition of neurogenesis.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14688397     DOI: 10.1634/stemcells.22-1-109

Source DB:  PubMed          Journal:  Stem Cells        ISSN: 1066-5099            Impact factor:   6.277


  56 in total

1.  The HIV-1 coat protein gp120 regulates CXCR4-mediated signaling in neural progenitor cells.

Authors:  Phuong B Tran; Dongjun Ren; Richard J Miller
Journal:  J Neuroimmunol       Date:  2004-12-28       Impact factor: 3.478

Review 2.  [The relevance of the inflammatory response in the injured brain].

Authors:  O I Schmidt; I Leinhase; E Hasenboehler; S J Morgan; P F Stahel
Journal:  Orthopade       Date:  2007-03       Impact factor: 1.087

Review 3.  Mitogen-activated protein kinase p38 in HIV infection and associated brain injury.

Authors:  Kathryn E Medders; Marcus Kaul
Journal:  J Neuroimmune Pharmacol       Date:  2011-02-01       Impact factor: 4.147

4.  Disruption of CXCR4 enhances osteoclastogenesis and tumor growth in bone.

Authors:  Angela C Hirbe; Jessica Rubin; Ozge Uluçkan; Elizabeth A Morgan; Mark C Eagleton; Julie L Prior; David Piwnica-Worms; Katherine N Weilbaecher
Journal:  Proc Natl Acad Sci U S A       Date:  2007-08-22       Impact factor: 11.205

Review 5.  Multiple roles of chemokine CXCL12 in the central nervous system: a migration from immunology to neurobiology.

Authors:  Meizhang Li; Richard M Ransohoff
Journal:  Prog Neurobiol       Date:  2007-11-26       Impact factor: 11.685

Review 6.  G-protein-coupled receptors in adult neurogenesis.

Authors:  Van A Doze; Dianne M Perez
Journal:  Pharmacol Rev       Date:  2012-05-18       Impact factor: 25.468

7.  Ageing: Blood ties.

Authors:  Richard M Ransohoff
Journal:  Nature       Date:  2011-08-31       Impact factor: 49.962

Review 8.  HIV's double strike at the brain: neuronal toxicity and compromised neurogenesis.

Authors:  Marcus Kaul
Journal:  Front Biosci       Date:  2008-01-01

9.  Fractalkine and CX 3 CR1 regulate hippocampal neurogenesis in adult and aged rats.

Authors:  Adam D Bachstetter; Josh M Morganti; Jennifer Jernberg; Andrea Schlunk; Staten H Mitchell; Kaelin W Brewster; Charles E Hudson; Michael J Cole; Jeffrey K Harrison; Paula C Bickford; Carmelina Gemma
Journal:  Neurobiol Aging       Date:  2009-12-16       Impact factor: 4.673

10.  Molecular correlates of axonal and synaptic pathology in mouse models of Batten disease.

Authors:  Catherine Kielar; Thomas M Wishart; Alice Palmer; Sybille Dihanich; Andrew M Wong; Shannon L Macauley; Chun-Hung Chan; Mark S Sands; David A Pearce; Jonathan D Cooper; Thomas H Gillingwater
Journal:  Hum Mol Genet       Date:  2009-07-29       Impact factor: 6.150

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.